**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 367-30-6 |2,5-Difluoroaniline | 99 | 206-690-1 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
May cause eye irritation. May cause chemical conjunctivitis and
corneal damage.
Skin:
Causes skin irritation. Harmful if absorbed through the skin. May
cause skin sensitization, an allergic reaction, which becomes
evident upon re-exposure to this material. May cause cyanosis of the
extremities.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. The toxicological properties of this substance have not
been fully investigated. Methemoglobinemia is characterized by
dizziness, drowsiness, headache, shortness of breath, cyanosis
(bluish discoloration of skin due to deficient oxygenation of the
blood), rapid heart rate and chocolate-brown colored blood.
Overexposure may cause methemoglobinemia.
Inhalation:
Causes respiratory tract irritation. The toxicological properties of
this substance have not been fully investigated. Aspiration may lead
to pulmonary edema. Methemoglobinemia is characterized by dizziness,
drowsiness, headache, shortness of breath, cyanosis (bluish
discoloration of skin due to deficient oxygenation of the blood),
rapid heart rate and chocolate-brown blood. Inhalation of aniline
causes anoxia due to the formation of methemoglobin. Inhalation at
high concentrations may cause CNS depression and asphixiation.
Chronic:
May cause methemoglobinemia, which is characterized by
chocolate-brown colored blood, headache, weakness, dizziness, breath
shortness, cyanosis (bluish skin due to deficient oxygenation of
blood), rapid heart rate, unconsciousness and possible death.
Repeated exposure may cause sensitization dermatitis.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
For methemoglobinemia, administer oxygen alone or with Methylene
Blue depending on the methemoglobin concentration in the blood.
Antidote:
Methylene blue, alone or in combination with oxygen is indicated as
a treatment in nitrite induced methemoglobinemia.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Use water spray to keep fire-exposed containers
cool. Vapors may be heavier than air. They can spread along the
ground and collect in low or confined areas. Combustible liquid and
vapor. Approach fire from upwind to avoid hazardous vapors and toxic
decomposition products.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Remove all
sources of ignition. Use a spark-proof tool. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Avoid contact with eyes, skin, and
clothing. Empty containers retain product residue, (liquid and/or
vapor), and can be dangerous. Keep container tightly closed. Keep
away from heat, sparks and flame. Do not pressurize, cut, weld,
braze, solder, drill, grind, or expose empty containers to heat,
sparks or open flames. Use only with adequate ventilation. Avoid
breathing vapor or mist.
Storage:
Keep away from sources of ignition. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances. Isolate from oxidizing materials and acids.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 367-30-6:
Personal Protective Equipment
Eyes:
Wear chemical splash goggles.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear brown
Odor: aniline-like
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 176-178 deg C @ 760 mmHg
Freezing/Melting Point: 13-14 deg C
Autoignition Temperature: Not available.
Flash Point: 68 deg C ( 154.40 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density: 1.2880g/cm3
Molecular Formula: C6H5F2N
Molecular Weight: 129.11
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Ignition sources, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, acids.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, hydrogen fluoride
gas, aniline.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 367-30-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2,5-Difluoroaniline -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: FLUOROANILINES
Hazard Class: 6.1
UN Number: 2941
Packing Group: III
IMO
Shipping Name: FLUOROANILINES
Hazard Class: 6.1
UN Number: 2941
Packing Group: III
RID/ADR
Shipping Name: FLUOROANILINES
Hazard Class: 6.1
UN Number: 2941
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 367-30-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 367-30-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 367-30-6 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #3 Date: 5/13/2002
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Ethyl N-(Diphenylmethylene)glycinate, 98%
| 69555-14-2 |
|
Methyl 4-(hydroxymethyl)benzoate, 98%
| 6908-41-4 |
|
Glyoxylic acid monohydrate, 98%
| 298-12-4 |
|
Trimethylhydroquinone, 97%
| 700-13-0 |
|
2,5-Difluoroaniline, 99%
| 367-30-6 |
|
Phosphoenolpyruvic acid cyclohexylamine salt, 98% (titr.)
| 10526-80-4 |
|
Exo-2-Chloro-5,5-Ethylenedioxy-Bicyclo[2.2.1]Heptane-Syn-7-Carboxylic
| 64812-08-4 |
|
6-Methyl-2-pyridinecarboxaldehyde, 97%
| 1122-72-1 |
|
Methyl methylsulfinylmethyl sulfide, 97%
| 33577-16-1 |
|
Trans-2,3-Dibromo-2-Butene-1,4-Diol, 97%
| 3234-02-4 |
|
1-Bromo-2,5-Dichloro-3-Fluorobenzene, 98%
| 0-00-1 |
|
(r)-(-)-Methyl mandelate, 98+%
| 20698-91-3 |
|
3-Bromo-4-Chlorobenzotrifluoride, 98+%
| 454-78-4 |
|
3-Nitrophthalic anhydride, 97%
| 641-70-3 |
|
Phenylphosphonic dichloride, 97%
| 824-72-6 |
|
5-tert-Butyl-m-xylene, 98%
| 98-19-1 |
|
2,4-Dibromophenol, 99% (GC)
| 615-58-7 |
|
Ytterbium(iii) oxide, 99%
| 1314-37-0 |
|
1,3-Indanedione, 97%
| 606-23-5 |
|
Nitrilotriacetic Acid, 99%
| 139-13-9 |
|
3-Ethoxypropionaldehyde diethyl acetal, 95%
| 7789-92-6 |
|
N-(Alpha, Alpha, Alpha-Trifluoro-M-Tolyl)Piperazine, 98%(Titr.)
| 15532-75-9 |
|
p-Bromoaniline
| 106-40-1 |
|
3-Hydroxy-3,7,11-Trimethyl-1,6,10-Dodecatriene, mixture of cis-trans,
| 7212-44-4 |
|
N-(Gamma-L-Glutamyl)-Alpha-Naphthylamide Monohydrate, 99%
| 81012-91-1 |
|
Acridine Yellow, 98% (UV-Vis)
| 135-49-9 |
|
Dibutyltin oxide, 98%
| 818-08-6 |
|
Dimethyl 4-nitrophthalate
| 610-22-0 |
|
1-Octadecene, Tech., 90%
| 112-88-9 |
|
Dibenzyl Malonate, Tech., 90%
| 15014-25-2 |
|
3-O-methyldopamine hydrochloride, p.a.
| 1477-68-5 |
|
3-Hydroxybenzophenone, 99%
| 13020-57-0 |
|
2,5-Dichloronitrobenzene, 99%
| 89-61-2 |
|
Diphenylsilanediol, 95%
| 947-42-2 |
|
Allyl glycidyl ether, 99+ %
| 106-92-3 |
|
(+)-Dihydrocarvone, 98%, mixture of isomers
| 5524-05-0 |
|
Semicarbazide Hydrochloride,98%
| 563-41-7 |
|
3-Fluoro-4-Nitrotoluene, 99+%
| 446-34-4 |
|
2,3-Dichloronitrobenzene, 99%
| 3209-22-1 |
|
N-(3-Bromo-2,4,6-Trimethylphenylcarbamoylmethyl)Iminodiacetic Acid,
| 78266-06-5 |
|
(3R,4R)-(-)-D-Erythronolactone, 99.5+%
| 15667-21-7 |
|
2-Phenylcyclohexanone, 98%
| 1444-65-1 |
|
4,4'-Dimethoxystilbene, 97%
| 4705-34-4 |
|
Ethyl-2-(2-Aminothiazol-4-yl)-2-Hydroxyimino Acetate, 97%,
| 64485-82-1 |
|
Benzo[b]tellurophene, 96%
| 0-01-0 |
|
Ethyl Isocyanoacetate, 97+% (GC)
| 2999-46-4 |
|
Chlorodiphenylphosphine, Tech., 95%
| 1079-66-9 |
|
4-Hydroxyephedrine hydrochloride, 99+%
| 7437-54-9 |
|
p-Toluoyl chloride, 98%
| 874-60-2 |
|
2,4-Difluoronitrobenzene, 99%
| 446-35-5 |
|
|